FDA has announced emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for those aged 12-15 years old. Previously authorization had been provided for those 16 on December 11, 2021. Studies for those under the age of 12 years old are already underway and authorization is expected to be provided by the end of the year.